In The News

Quae cum essent dicta, discessimus. Quis suae urbis conservatorem Codrum, quis Erechthei filias non maxime laudat? Quod autem satis est.

In The News

A non-opioid pain startup believes it can top the bupivacaine market — and it’s thinking in terms of weeks, not days

Endpoints  |  May 13, 2021

By: Kyle Blankenship, Managing Editor The road to non-opioid pain management has swallowed biotech players…